Commissioner Defends FDA On Duodenoscope, LDT Actions At Senate Hearing
This article was originally published in The Gray Sheet
Executive Summary
In her last appearance before a Senate committee March 10, FDA Commissioner Margaret Hamburg presented a strong defense of FDA’s actions to address contaminated duodenoscopes, regulation of lab developed tests and other hot button issues raised by Senators, who also praised her leadership at FDA.
You may also be interested in...
‘No Plans’ To Change Duodenoscope Cleaning Guide, But Cooperating With FDA, Pentax Says
While Olympus has already updated its cleaning protocol in response to outbreak of bacterial infections and FDA recommendations, another duodenoscope maker, Pentax, says it has no specific plans to change instructions or designs for its devices. An FDA panel met May 14-15 to discuss duodenoscope safety and make recommendations.
Visual Podcast: 10 Tips For Writing Effective IFUs For Medical Devices – And More
In the wake of troubling patient infections and deaths due to improperly sterilized duodenoscopes, human factors experts Michael Wiklund and Jonathan Kendler of UL-Wiklund Research & Design provide tips on writing effective instructions for use in this "Silver Sheet" visual podcast.
PODCAST: 10 Tips For Writing Effective IFUs For Medical Devices – And More
Online-Only Content >>> In the wake of troubling patient infections and deaths due to improperly sterilized duodenoscopes, human factors experts Michael Wiklund and Jonathan Kendler of UL-Wiklund Research & Design provide tips on writing effective instructions for use in this "Silver Sheet" podcast.